Merck debuts HIV/AIDS video series

Share this article:

Merck bolstered its HIV/AIDS education effort with a new online video series starring Jack Mackenroth of Project Runway.

The unbranded video series, titled Living Positive By Design: Creating Positive Conversations, is an extension of the Merck-sponsored speaking tour featuring Mackenroth, and hopes to educate people about managing HIV/AIDS and the social elements and stigma that the disease can carry. Videos will appear on the campaign's MySpace page.

The first video in the series follows Mackenroth through Chicago, where he interviews Chris Brown, assistant commissioner for the Chicago Department of Public Health's STD/HIV/AIDS division, visits a bakery that supports HIV-positive individuals and speaks with Daniel Berger, a professor at the University of Illinois' college of medicine, and the director of NorthStar Medical Center.

The video components of the campaign were created by New Jersey-based M-Street Creative, with PR handled by Cohn & Wolfe. Digital agency VM Foundry built a widget allowing consumers to share the video content on social networks.

Last June, Merck received an extended indication for Isentress, the first medication to receive approval in a new class of HIV medications called integrase inhibitors, according to the brand site. That product is now approved for previously untreated patients, and is usually prescribed in combination with standard treatment. 

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...